Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Accounts Payables: 2019-2023

Historic Accounts Payables for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $9.0 million.

  • ADC Therapeutics' Accounts Payables fell 22.69% to $9.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.0 million, marking a year-over-year decrease of 22.69%. This contributed to the annual value of $12.4 million for FY2022, which is 2.24% up from last year.
  • ADC Therapeutics' Accounts Payables amounted to $9.0 million in Q3 2023, which was down 23.21% from $11.7 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Accounts Payables ranged from a high of $16.5 million in Q1 2022 and a low of $6,146 during Q3 2020.
  • Moreover, its 3-year median value for Accounts Payables was $12.0 million (2021), whereas its average is $12.1 million.
  • Per our database at Business Quant, ADC Therapeutics' Accounts Payables skyrocketed by 215,156.73% in 2021 and then plummeted by 47.16% in 2023.
  • Over the past 5 years, ADC Therapeutics' Accounts Payables (Quarterly) stood at $3.3 million in 2019, then reached $6,146 in 2020, then soared by 195,604.52% to $12.1 million in 2021, then climbed by 2.24% to $12.4 million in 2022, then declined by 22.69% to $9.0 million in 2023.
  • Its last three reported values are $9.0 million in Q3 2023, $11.7 million for Q2 2023, and $8.7 million during Q1 2023.